References
- Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996, 87, 13-20 https://doi.org/10.1016/S0092-8674(00)81318-5
- Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336, 1066-1071 https://doi.org/10.1056/NEJM199704103361506
- Beg AA, Baldwin AS Jr. The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev 1993, 7, 2064-2070 https://doi.org/10.1101/gad.7.11.2064
- Beg AA, Baltimore D. An essential role for NFkappaB in preventing TNF-alpha-induced cell death. Science 1996, 274, 782-784 https://doi.org/10.1126/science.274.5288.782
- Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol 1993, 13, 3301-3310 https://doi.org/10.1128/MCB.13.6.3301
- Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376, 167-170 https://doi.org/10.1038/376167a0
- Berg-Brown NN, Gronski MA, Jones RG, Elford AR, Deenick EK, Odermatt B, Littman DR, Ohashi PS. PKC{theta} Signals Activation versus Tolerance In Vivo. J Exp Med 2004, 199, 743-752 https://doi.org/10.1084/jem.20031022
- Brocke S, Piercy C, Steinman L, Weissman IL, Veromaa T. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci USA 1999, 96, 6896-6901
- Brown K, Park S, Kanno T, Franzoso G, Siebenlist U. Mutual regulation of the transcriptional activator Nfkappa B and its inhibitor, I kappa B-alpha. Proc Natl Acad Sci USA 1993, 90, 2532-2536
- Chandler S, Miller KM, Clements JM, Lury J, Corkill D, Anthony DC, Adams SE, Gearing AJ. Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview. J Neuroimmunol 1997, 72, 155-161 https://doi.org/10.1016/S0165-5728(96)00179-8
- Flores N, Duran C, Blasco MR, Puerta C, Dorado B, Garcia-Merino A, Ballester S. NFkappaB and AP-1 DNA binding activity in patients with multiple sclerosis. J Neuroimmunol 2003, 135, 141-147 https://doi.org/10.1016/S0165-5728(02)00440-X
- Greene WC, Bohnlein E, Ballard DW. HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises. Immunol Today 1989, 10, 272-278 https://doi.org/10.1016/0167-5699(89)90141-2
- Grilli M, Chiu JJ, Lenardo MJ. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol 1993, 143, 1-62 https://doi.org/10.1016/S0074-7696(08)61873-2
- Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 1993, 365, 182-185 https://doi.org/10.1038/365182a0
- Hilliard B, Samoilova EB, Liu TS, Rostami A, Chen Y. Experimental autoimmune encephalomyelitis in NF-kappa B-deficient mice: roles of NF-kappa B in the activation and differentiation of autoreactive T cells. J Immunol 1999, 163, 2937-2943
- Ishikawa H, Claudio E, Dambach D, Raventos-Suarez C, Ryan C, Bravo R. Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. J Exp Med 1998, 187, 985-996 https://doi.org/10.1084/jem.187.7.985
- Kuo CT, Leiden JM. Transcriptional regulation of T lymphocyte development and function. Annu Rev Immunol 1999, 17, 149-187 https://doi.org/10.1146/annurev.immunol.17.1.149
- Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989, 58, 227-229 https://doi.org/10.1016/0092-8674(89)90833-7
- Leppert D, Lindberg RL, Kappos L, Leib SL. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res Brain Res Rev 2001, 36, 249-257 https://doi.org/10.1016/S0165-0173(01)00101-1
- Liang Q, Bueno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD. c-Jun N-terminal kinases (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO J 2003, 22, 5079-5089 https://doi.org/10.1093/emboj/cdg474
- Liu SF, Ye X, Malik AB. In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997, 159, 3976-3983
- Martin R, McFarland HF. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit Rev Clin Lab Sci 1995, 32, 121-182 https://doi.org/10.3109/10408369509084683
- Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996, 19, 331-338 https://doi.org/10.1016/0166-2236(96)10047-3
- O'Connor KC, Bar-Or A, Hafler DA. The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis. J Clin Immunol 2001, 21, 81-92 https://doi.org/10.1023/A:1011064007686
- Olsson T. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol Rev 1995, 144, 245-268 https://doi.org/10.1111/j.1600-065X.1995.tb00072.x
- Pahan K, Schmid M. Activation of nuclear factor-kB in the spinal cord of experimental allergic encephalomyelitis. Neurosci Lett 2000, 287, 17-20 https://doi.org/10.1016/S0304-3940(00)01167-8
- Raine CS. The Norton Lecture: a review of the oligodendrocyte in the multiple sclerosis lesion. J Neuroimmunol 1997, 77, 135-152 https://doi.org/10.1016/S0165-5728(97)00073-8
- Raine CS, Traugott U. Experimental autoimmune demyelination. Chronic relapsing models and their therapeutic implications for multiple sclerosis. Ann N Y Acad Sci 1984, 436, 33-51 https://doi.org/10.1111/j.1749-6632.1984.tb14774.x
- Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997, 15, 707-747 https://doi.org/10.1146/annurev.immunol.15.1.707
- Sha WC, Liou HC, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 1995, 80, 321-330 https://doi.org/10.1016/0092-8674(95)90415-8
- Shin T, Kojima T, Tanuma N, Ishihara Y, Matsumoto Y. The subarachnoid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J Neuroimmunol 1995, 56, 171-178 https://doi.org/10.1016/0165-5728(94)00144-D
- Steffen BJ, Butcher EC, Engelhardt B. Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse. Am J Pathol 1994, 145, 189-201
- Sun SC, Ganchi PA, Ballard DW, Greene WC. Nfkappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 1993, 259, 1912-1915 https://doi.org/10.1126/science.8096091
- Sun SC, Ganchi PA, Beraud C, Ballard DW, Greene WC. Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. Proc Natl Acad Sci USA 1994, 91, 1346-1350
- Thomas LH, Friedland JS, Sharland M, Becker S. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on nuclear factor-kappa B nuclear binding and is inhibited by adenovirus-mediated expression of inhibitor of kappa B alpha. J Immunol 1998, 161, 1007-1016
- Ting AT, Pimentel-Muinos FX, Seed B. RIP mediates tumor necrosis factor receptor 1 activation of NFkappaB but not Fas/APO-1-initiated apoptosis. EMBO J 1996, 15, 6189-6196
- Tsitoura DC, Rothman PB. Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells. J Clin Invest 2004, 113, 619-627 https://doi.org/10.1172/JCI200418975
- Wingren AG, Parra E, Varga M, Kalland T, Sjogren HO, Hedlund G, Dohlsten M. T cell activation pathways: B7, LFA-3, and ICAM-1 shape unique T cell profiles. Crit Rev Immunol 1995, 15, 235-253 https://doi.org/10.1615/CritRevImmunol.v15.i3-4.30
- Yang Y, Villain P, Mustelin T, Couture C. Critical role of Ser-520 phosphorylation for membrane recruitment and activation of the ZAP-70 tyrosine kinase in T cells. Mol Cell Biol 2003, 23, 7667-7677 https://doi.org/10.1128/MCB.23.21.7667-7677.2003